Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia

NCT05692258 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine as lead sponsor.

NCT NCT05692258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia
Lead sponsor
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
January 6, 2023
Completion date
April 6, 2023
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acupuncture, covid-19 omicron, pulmonary function